ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.

There are few data regarding ZAC1 expression in clinically non-functioning pituitary adenomas (NFPA). Because somatotropinomas and NFPA behave differently with respect to tumor shrinkage during somatostatin analogs (SA) therapy, we sought to compare the ZAC1 and somatostatin receptor (sstr) types 1,...

Full description

Bibliographic Details
Main Authors: Leonardo Vieria Neto, Luiz Eduardo Wildemberg, Leandro Machado Colli, Leandro Kasuki, Nelma Veronica Marques, Aline Barbosa Moraes, Emerson L Gasparetto, Christina Maeda Takiya, Margaret Castro, Mônica Roberto Gadelha
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3788723?pdf=render